Ariad Pharmaceuticals (ARIA) Down amid Reports of Sale

Ariad Pharmaceuticals, Inc.

fell 5.2% to $9.38. Ariad Pharmaceuticals shares jumped 41.7% Friday, on a report from the Boston Globe that the biotech company was in talks to sell itself to Baxalta Inc. according to sources. Share volume was 5.7 million, compared to an all-day average of 3.6 million